Abstract
Nanotheranostics is a real-time integration of novel therapeutic and diagnostic tool or imaging in one system, linked and integrated by nanoparticles. It is one of the biggest scientific breakthroughs in nanomedicine and is extremely attractive for personalized medicine. In this chapter, we aim to introduce the reader to the various particles and terminologies associated with nanomedicine with the aid of fifteen questions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Zhang P, Zhang L, Qin Z, Hua S, Guo Z, Chu C, et al. Genetically engineered liposome-like nanovesicles as active targeted transport platform. Adv Mater. 2018;30:1705350. https://doi.org/10.1002/adma.201705350.
Muthu MS, Leong DT, Mei L, Feng SS. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics. Theranostics. 2014;4(6):660–77. https://doi.org/10.7150/thno.8698.
Martinelli C, Pucci C, Ciofani G. Nanostructured carriers as innovative tools for cancer diagnosis and therapy. APL Bioeng. 2019;3(1):011502. https://doi.org/10.1063/1.5079943.
d’Angelo M, Castelli V, Benedetti E, et al. Theranostic nanomedicine for malignant gliomas. Front Bioeng Biotechnol. 2019;7:325. [published correction appears Front Bioeng Biotechnol. 2020 7:468], Published 2019 Nov 14. https://doi.org/10.3389/fbioe.2019.00325.
Bozzato E, Bastiancich C, Préat V. Nanomedicine: a useful tool against Glioma stem cells. Cancers (Basel). 2020;13(1):9. https://doi.org/10.3390/cancers13010009.
Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2(4):M17–71. https://doi.org/10.1116/1.2815690.
Pijeira MSO, Viltres H, Kozempel J, Sakmár M, Vlk M, İlem-Özdemir D, Ekinci M, Srinivasan S, Rajabzadeh AR, Ricci-Junior E, Alencar LMR, Al Qahtani M, Santos-Oliveira R. Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology. EJNMMI Radiopharm Chem. 2022;7(1):8. https://doi.org/10.1186/s41181-022-00161-4.
Rizvi SA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018;26(1):64–70. https://doi.org/10.1016/j.jsps.2017.10.012.
Zein R, Sharrouf W, Selting K. Physical properties of nanoparticles that result in improved cancer targeting. J Oncol. 2020;2020:1–16. https://doi.org/10.1155/2020/5194780.
Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today. 2014;9(2):223–43. https://doi.org/10.1016/j.nantod.2014.04.008.
Dennahy IS, Han Z, MacCuaig WM, Chalfant HM, Condacse A, Hagood JM, Claros-Sorto JC, Razaq W, Holter-Chakrabarty J, Squires R, Edil BH, Jain A, McNally LR. Nanotheranostics for image-guided cancer treatment. Pharmaceutics. 2022;14(5):917. https://doi.org/10.3390/pharmaceutics14050917.
Naik K, Chaudhary S, Ye L, Parmar AS. A strategic review on carbon quantum dots for cancer-diagnostics and treatment. Front Bioeng Biotechnol. 2022;18(10):882100. https://doi.org/10.3389/fbioe.2022.882100.
Cortajarena AL, Ortega D, Ocampo SM, Gonzalez-GarcÃa A, Couleaud P, Miranda R, Belda-Iniesta C, Ayuso-Sacido A. Engineering iron oxide nanoparticles for clinical settings. Nanobiomedicine (Rij). 2014;1(1):2. https://doi.org/10.5772/58841.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Das, J.M. (2023). Nanotheranostics. In: Neuro-Oncology Explained Through Multiple Choice Questions. Springer, Cham. https://doi.org/10.1007/978-3-031-13253-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-031-13253-7_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13252-0
Online ISBN: 978-3-031-13253-7
eBook Packages: MedicineMedicine (R0)